Arrowhead Pharmaceuticals
ARWR
#2034
Rank
โ‚น843.57 B
Marketcap
โ‚น6,101
Share price
2.54%
Change (1 day)
251.88%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -โ‚น104.69

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น111.90. In 2024 the company made an earnings per share (EPS) of -โ‚น447.58 a decrease over its 2023 EPS that were of -โ‚น171.24.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น104.69-76.61%
2024-โ‚น447.58161.39%
2023-โ‚น171.2417.36%
2022-โ‚น145.9119.85%
2021-โ‚น121.7461.9%
2020-โ‚น75.19-216.67%
2019โ‚น64.45-210.77%
2018-โ‚น58.1938.3%
2017-โ‚น42.07-64.93%
2016-โ‚น119.95-16.25%
2015-โ‚น143.2328%
2014-โ‚น111.90-3.85%
2013-โ‚น116.37-31.58%
2012-โ‚น170.08331.82%
2011-โ‚น39.39-51.11%
2010-โ‚น80.57-79.07%
2009-โ‚น384.92-37.68%
2008-โ‚น617.67-16.87%
2007-โ‚น742.9938.33%
2006-โ‚น537.10122.22%
2005-โ‚น241.7042.11%
2004-โ‚น170.08533.33%
2003-โ‚น26.86-99.08%
2002-โ‚น2,90625%
2001-โ‚น2,32533.33%
2000-โ‚น1,744-120%
1999โ‚น8,719-400%
1998-โ‚น2,906-81.48%
1997-โ‚น15,695

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚น8.06-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น213.95-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น257.81 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น934.50-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น722.40 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA